The U.S. Food and Drug Administration (FDA) has approved two new biosimilars as reference products for Prolia (denosumab) and ...

The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left people on both sides of the reproductive rights fight scrambling to interpret ...

In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...

The healthtech industry is on track to triple from $352 in 2025 to over $1.1T by 2032, driven by critical needs in provider capacity, aging populations, and chronic disease management.

Louisville Metro Police collect data through license plate readers and share it with thousands of law enforcement agencies.

The number of people suspected of dying from substance use in Manitoba is dropping for the first time in recent years, but the government body tracking the data says optimism around the decline ...

More than 13,000 people have been charged in LA, Orange and Riverside counties since the measure’s passage, mostly for repeat drug offenses.

The Abortion Care in Victoria report is not progress – it is propaganda promoted to the public as ‘reproductive justice’.

The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ...

Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness.

The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct.